EXO MEDICAL LIMITED
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2025-03-31 |
|---|---|
| Average employees | 2 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (5 events)Click to expand
- 2025-12-14📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-03-22🏢Company incorporatedAs EXO MEDICAL LIMITED
- 2024-03-22➕MITCHELL, Paul William, Dr appointeddirector
- 2024-03-22➕THOMAS, Kate, Dr appointeddirector
- 2024-03-22📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Young company: Only 2.1 years old — management layer unlikely to be developed.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Kate Thomas Individual · British · DOB 03/1982 · age 44 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 22/03/2024 |
Dr Paul William Mitchell Individual · British · DOB 12/1971 · age 55 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 22/03/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| EIDYN CARE LTD→ SC544001 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| ELM PHYSIO LTD→ SC820810 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ENCHANTED FOREST NURSERY (INVERKIP) LTD→ SC412812 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ENGAGE CLINICAL PSYCHOLOGY LTD→ SC666815 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ENNYY LIMITED→ SC736563 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| EPI INTERVENTIONS LTD→ SC489789 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| EPIC ASSIST CHARITY→ SC455459 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| EYE SIRJHUN LTD→ SC846282 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| EYECARE-PLUS LTD→ SC249898 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| FAMILY FIRST NURSERIES LIMITED→ SC704550 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| FIFE COAST LOCUMS LIMITED→ SC833631 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| FN HEALTHCARE PVT LTD.→ SC626327 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.